MLTX
Price
$20.41
Change
+$0.05 (+0.25%)
Updated
Jul 13 closing price
Capitalization
1.71B
30 days until earnings call
Intraday BUY SELL Signals
NUVL
Price
$123.94
Change
+$0.04 (+0.03%)
Updated
Jul 13, 04:59 PM (EDT)
Capitalization
9.8B
24 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MLTX vs NUVL

MLTX vs NUVL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
MLTX vs. NUVL commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLTX is a Hold and NUVL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (MLTX: $20.36 vs. NUVL: $123.90)
Brand notoriety: MLTX and NUVL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLTX: 106% vs. NUVL: 41%
Market capitalization -- MLTX: $1.71B vs. NUVL: $9.81B
MLTX [@Biotechnology] is valued at $1.71B. NUVL’s [@Biotechnology] market capitalization is $9.81B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLTX’s FA Score shows that 0 FA rating(s) are green whileNUVL’s FA Score has 0 green FA rating(s).

  • MLTX’s FA Score: 0 green, 5 red.
  • NUVL’s FA Score: 0 green, 5 red.
According to our system of comparison, both MLTX and NUVL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLTX’s TA Score shows that 6 TA indicator(s) are bullish while NUVL’s TA Score has 5 bullish TA indicator(s).

  • MLTX’s TA Score: 6 bullish, 4 bearish.
  • NUVL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than NUVL.

Price Growth

MLTX (@Biotechnology) experienced а +7.44% price change this week, while NUVL (@Biotechnology) price change was +0.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.13%. For the same industry, the average monthly price growth was +7.30%, and the average quarterly price growth was +1806.57%.

Reported Earning Dates

MLTX is expected to report earnings on Aug 12, 2026.

NUVL is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (-3.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NUVL($9.8B) has a higher market cap than MLTX($1.71B). MLTX YTD gains are higher at: 54.476 vs. NUVL (23.173). MLTX has higher annual earnings (EBITDA): -245.81M vs. NUVL (-438.9M). NUVL has more cash in the bank: 1.29B vs. MLTX (358M). MLTX (0) and NUVL (0) have equivalent revenues.
MLTXNUVLMLTX / NUVL
Capitalization1.71B9.8B17%
EBITDA-245.81M-438.9M56%
Gain YTD54.47623.173235%
P/E RatioN/AN/A-
Revenue00-
Total Cash358M1.29B28%
Total Debt101MN/A-
TECHNICAL ANALYSIS
Technical Analysis
MLTXNUVL
RSI
ODDS (%)
Bearish Trend 4 days ago
61%
Bearish Trend 4 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
82%
Momentum
ODDS (%)
Bullish Trend 4 days ago
68%
Bullish Trend 4 days ago
86%
MACD
ODDS (%)
Bearish Trend 4 days ago
63%
Bearish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 12 days ago
77%
Bearish Trend 18 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
74%
Bearish Trend 4 days ago
83%
Aroon
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
MLTX
Daily Signal:
Gain/Loss:
NUVL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DVYE33.250.46
+1.40%
iShares Emerging Markets Dividend ETF
CCOR25.920.06
+0.25%
Core Alternative Capital
FLAG28.00N/A
N/A
Global X S&P 500 U.S. Market Leaders Top 50 ETF
NLSI53.12N/A
N/A
NEOS Long/Short Equity Income ETF
DMB10.92-0.08
-0.73%
BNY Mellon Municipal

NUVL and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVL has been loosely correlated with MLTX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVL jumps, then MLTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVL
1D Price
Change %
NUVL100%
+0.06%
MLTX - NUVL
49%
Loosely correlated
+2.16%
XNCR - NUVL
42%
Loosely correlated
-1.64%
PCVX - NUVL
41%
Loosely correlated
-2.71%
PTGX - NUVL
39%
Loosely correlated
-4.52%
GOSS - NUVL
39%
Loosely correlated
-3.03%
More